OPPENHEIMER ASSET MANAGEMENT INC. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,075,139
+6.1%
28,145
+0.2%
0.02%
+6.7%
Q2 2023$1,013,242
-5.4%
28,091
+0.1%
0.02%
-11.8%
Q1 2023$1,071,574
-59.1%
28,059
-39.0%
0.02%
-59.5%
Q4 2022$2,616,945
+53.8%
45,992
+6.9%
0.04%
+40.0%
Q3 2022$1,701,000
-0.5%
43,028
+10.7%
0.03%
+3.4%
Q2 2022$1,710,000
+11.0%
38,863
+0.6%
0.03%
+31.8%
Q1 2022$1,541,000
+0.6%
38,647
+1.4%
0.02%
+10.0%
Q4 2021$1,532,000
-12.0%
38,100
-11.0%
0.02%
-20.0%
Q3 2021$1,741,000
+16.2%
42,786
+29.7%
0.02%
+19.0%
Q2 2021$1,498,000
+8.9%
32,982
-0.1%
0.02%0.0%
Q1 2021$1,376,000
+40.7%
33,000
+44.2%
0.02%
+31.2%
Q4 2020$978,000
+65.2%
22,891
+1.7%
0.02%
+45.5%
Q3 2020$592,000
+1.0%
22,506
+3.0%
0.01%
-8.3%
Q2 2020$586,000
+860.7%
21,860
+541.2%
0.01%
+1100.0%
Q1 2020$61,0003,4090.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders